Immune Checkpoint Inhibitor-Induced Psoriasis: Diagnosis, Management, and a Review of Cases
Dermatologic Clinics(2024)
摘要
Immune checkpoint inhibitors (ICIs) are effective antitumor agents but are associated with immune-related adverse events. ICI-induced psoriasis commonly presents in patients with a history of psoriasis but may occur de novo, and it has a significant physical and psychosocial impact. ICI-induced and non-ICI-induced psoriasis are likely mediated by similar cytokines, and similar treatments are employed. Topical treatment often suffices, and when needed, several systemic treatments appear to be effective without impacting antitumor response. Development of psoriasis may indicate a superior response to ICIs. Thus, recognition and management of ICI-induced psoriasis is essential to avoid ICI interruption and maximize therapeutic potential.
更多查看译文
关键词
Immune checkpoint inhibitor,Immunotherapy,Immune-related adverse event,Psoriasis,Dermatology,Oncology,Oncodermatology
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要